TABLE 2.
Avidity index | No. (%) of specimens from primary infection at moa:
|
No. (%) of specimens from nonprimary infection | |||||
---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | ≥6 | ||
0.01–0.09 | 9 (25.0) | 2 (5.0) | |||||
0.10–0.19 | 19 (52.8) | 13 (32.5) | 4 (22.2) | 1 (4.8) | |||
0.20–0.29 | 5 (13.9) | 8 (20.0) | 2 (11.1) | 2 (9.5) | 3 (15.0) | ||
0.30–0.4 | 1 (2.8) | 8 (20.0) | 7 (38.9) | 6 (28.6) | 1 (5.0) | ||
0.40–0.49 | 4 (10.0) | 5 (27.8) | 7 (33.3) | 2 (10.0) | |||
0.50–0.59 | 2 (5.6) | 0 (0.0) | 5 (23.8) | 8 (40.0) | 3 (12.5) | 4 (1.6) | |
0.60–0.69 | 2 (5.0) | 4 (20.0) | 8 (33.3) | 4 (1.6) | |||
0.70–0.79 | 3 (7.5) | 1 (5.0) | 7 (29.1) | 40 (15.6) | |||
0.80–0.89 | 1 (5.0) | 6 (25) | 130 (50.5) | ||||
>0.89 | 79 (30.7) | ||||||
Total | 36 (100) | 40 (100) | 18 (100) | 21 (100) | 20 (100) | 24 (100) | 257 (100) |
Time after onset of a CMV infection.